Kanu, Nnennaya
Cerone, Maria Antonietta
Goh, Gerald
Zalmas, Lykourgos-Panagiotis
Bartkova, Jirina
Dietzen, Michelle
McGranahan, Nicholas
Rogers, Rebecca
Law, Emily K.
Gromova, Irina
Kschischo, Maik
Walton, Michael I.
Rossanese, Olivia W.
Bartek, Jiri
Harris, Reuben S.
Venkatesan, Subramanian
Swanton, Charles
Funding for this research was provided by:
Cancer Research UK (TRACERx)
Cancer Research UK (TRACERx)
the CRUK Lung Cancer Centre of Excellence
Stand Up 2 Cancer Laura Ziskin prize (SU2C)
the Rosetrees Trust
NovoNordisk Foundation (16584)
EU FP7 (projects PREDICT and RESPONSIFY) (259303)
the Prostate Cancer Foundation
the Breast Cancer Research Foundation
the European Research Council (THESEUS) and National Institute for Health Research University College London Hospitals Biomedical Research Centre
Breast Cancer Research Foundation
Stand Up 2 Cancer
Breast Cancer Research Foundation
Breast Cancer Research Foundation
Cancer Research UK fellowship
Jimmy V Foundation for Cancer Research
Department of Defense Breast Cancer Research Program (BC121347)
Minnesota Ovarian Cancer Alliance (US)
Randy Shaver Cancer Research and Community Fund
Howard Hughes Medical Institute
Department of Defense Breast Cancer Research Program (BC121347)
Minnesota Ovarian Cancer Alliance
the Danish Cancer Society
the Novo Nordisk Foundation (16584)
the Danish Council for Independent Research (DFF-1331-00262B)
The Danish National Research Foundation (project CARD) (DNRF125)
the Swedish Research Council and CancerFonden (150733, 150733)
the Novo Nordisk Foundation (16584)
The Danish National Research Foundation (project CARD) (DNRF125)
CRUK programme grant to the Cancer Therapeutics Unit (C309/A11566)
Wellcome Trust studentship